People in the News: Linda McAllister, Mostafa Ronaghi | GenomeWeb

Linda McAllister has joined Toronto-based molecular diagnostics firm Xagenic as chief medical officer.

McAllister previously has worked on the development and launch of molecular technologies at Roche Diagnostics, Celera Diagnostics, and Affymetrix. She most recently was CMO at the prenatal genetic testing company Cellscape, and she was CMO and VP of R&D at Pharmajet. She also was an adjunct clinical professor in the University of California, San Francisco department of medicine from 1992 to 2005, and a research fellow at Stanford University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.